Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
AssigneesVrije Universiteit Brussel, Opus, Inc.
InventorsLuc Bouwens, Luc Baeyens
Life of this patent
Estimating the term…
Loading patent…
AssigneesVrije Universiteit Brussel, Opus, Inc.
InventorsLuc Bouwens, Luc Baeyens
Estimating the term…
The present invention relates to an in vitro method for generating insulin-producing beta cells from a population of mammalian cells comprising dedifferentiated exocrine pancreatic cells. The method comprises the step of culturing said dedifferentiated exocrine pancreatic cells in a culture medium in the presence of at least one agent that is able to inhibit the Notch 1 signaling pathway in said dedifferentiated exocrine pancreatic cells, and at least one ligand of the gp130 receptor and/or at least one ligand of the EGF receptor. The invention further provides a population of mammalian pancreatic cells comprising insulin-producing beta cells obtainable by the present method and uses thereof in a pharmaceutical composition for treating type 1 or type 2 diabetes.
An in vitro method for generating insulin-producing beta cells from a population of mammalian cells comprising dedifferentiated exocrine pancreatic cells comprising the step of culturing said dedifferentiated exocrine pancreatic cells in a culture medium in the presence of:
(canceled)
(canceled)
(canceled)
20-22. (canceled)
24-25. (canceled)
Dependencies are inferred from the claim text.